Clinical Trial Update: A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety assessment of different forms of AZD9496 in healthy subjects with breast cancer as the condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD9496

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-08-25